Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02587416Phase 1Completed
Phase 1, randomised trial of gemcabene in hypercholesterolemia (3 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Pharmacokinetics at Day 27. Started Nov 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02587416.